Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...
Funding will accelerate development of manufactured pancreatic beta cells capable of restoring insulin production using Syntax’s Cellgorithm™ technology Syntax Bio, a synthetic biology company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback